These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2604775)

  • 1. Time of administration of calcium acetate and phosphate binding.
    Diskin CJ; Thomas CE; Zellner CP
    N Engl J Med; 1989 Sep; 321(13):904-5. PubMed ID: 2604775
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the time of administration of calcium acetate on phosphorus binding.
    Schiller LR; Santa Ana CA; Sheikh MS; Emmett M; Fordtran JS
    N Engl J Med; 1989 Apr; 320(17):1110-3. PubMed ID: 2710173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure.
    Fröhling PT; Kokot F; Schmicker R; Kaschube I; Lindenau K; Vetter K
    Clin Nephrol; 1983 Oct; 20(4):212-5. PubMed ID: 6641029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication review: an alternative phosphate binder--calcium acetate.
    Holechek MJ
    ANNA J; 1991 Jun; 18(3):321-2. PubMed ID: 2064459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium acetate used as phosphate binding treatment in uremic hyperphosphatemia.
    Wikström B; Danielson BG; Fellström B
    Adv Perit Dial; 1991; 7():221-4. PubMed ID: 1680430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma catecholamine concentration and dopamine-beta-hydroxylase activity during haemodialysis with acetate or bicarbonate at different sodium concentrations in hypotensive patients.
    Ksiazek A; Solski J; Załuska W; Wawrzycki S; Słomka M
    Int Urol Nephrol; 1993; 25(4):401-7. PubMed ID: 8276569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of calcium acetate and calcium carbonate for the control of predialysis hyperphosphatemia].
    Djerad M; Morinière P; Westeel PF; el Esper N; Boitte F; Morsli R; Schenouda M; Compagnon M; Achard JM; Fournier A
    Nephrologie; 1991; 12(4):193-7. PubMed ID: 1745337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsatisfactory control of serum phosphate: why is it so common and what can be done?
    Schaefer K
    Nephrol Dial Transplant; 1994; 9(10):1366-7. PubMed ID: 7816245
    [No Abstract]   [Full Text] [Related]  

  • 10. [The embryotoxic action of calcium acetate in 24-hour inhalational body uptake].
    Govorunova NN; Grin' NV; Pavlovich LV; Bessmertnyĭ AN; Barinov EF; Nikolenko OI
    Gig Sanit; 1993 Jan; (1):17-8. PubMed ID: 8339957
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminum-free oral phosphate binder.
    Schneider H; Kulbe KD; Weber H; Streicher E
    Clin Nephrol; 1985; 24 Suppl 1():S98-102. PubMed ID: 3842107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does gastric acid secretion affect phosphate binding by aluminium phosphate binding gels in chronic renal failure?
    Cassidy M; Swanepoel C; Bridger S; Marks IN
    Nephrol Dial Transplant; 1988; 3(3):358. PubMed ID: 3140119
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between plasma sodium acetate concentration and systemic vascular resistances.
    Schohn DC; Klein S; Mitsuishi Y; Jahn HA
    Proc Eur Dial Transplant Assoc; 1981; 18():160-8. PubMed ID: 7329964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR monitoring of the energy status of skeletal muscle during hemodialysis using acetate.
    Cardoso M; Shoubridge E; Arnold D; Léveillé M; Prud'Homme M; St-Louis G; Vinay P
    Clin Invest Med; 1988 Aug; 11(4):292-6. PubMed ID: 3168351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal handling of calcium, magnesium and inorganic phosphate in chronic renal failure.
    Better OS; Kleeman CR; Gonick HC; Varrady PD; Maxwell MH
    Isr J Med Sci; 1967; 3(1):60-79. PubMed ID: 6047692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the parathyroid function, various biochemical parameters of calcium and phosphate metabolism and bone changes in chronic renal failure].
    Kontek M
    Pol Tyg Lek; 1980 Mar; 35(12):433-6. PubMed ID: 7383933
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study.
    Ring T; Nielsen C; Andersen SP; Behrens JK; Sodemann B; Kornerup HJ
    Nephrol Dial Transplant; 1993; 8(4):341-6. PubMed ID: 8390009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium in chronic kidney disease: myths and realities. Introduction.
    Langman CB; Cannata-Andía JB
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S1-2. PubMed ID: 20089497
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium and phosphate in renal failure.
    Br Med J; 1971 Jun; 2(5764):725-6. PubMed ID: 5090754
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged application of acetic acid for detection of flat vulval warts.
    Larsen J; Petersen CS; Weismann K
    Dan Med Bull; 1990 Jun; 37(3):286-7. PubMed ID: 2357911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.